The role of oestrogen receptor α in human thyroid cancer: contributions from coregulatory proteins and the tyrosine kinase receptor HER2 (vol 17, pg 255, 2010)

被引:0
|
作者
Kavanagh, Dara O. [1 ,2 ]
Mcilroy, Marie [1 ,2 ,3 ]
Myers, Eddie [1 ,2 ]
Bane, Fiona [3 ]
Crotty, Thomas B. [1 ,2 ]
Mcdermott, E. [1 ,2 ]
Hill, Arnold D. [1 ,2 ,3 ]
Young, Leonie S. [1 ,2 ,3 ]
机构
[1] St Vincents Univ Hosp, UCD Conway Inst, Sch Med & Med Sci, Dublin, Ireland
[2] Univ Coll Dublin, Dublin, Ireland
[3] Royal Coll Surgeons Ireland, Endocrine Oncol Res Grp, Dept Surg, St Stephens Green, Dublin, Ireland
关键词
D O I
10.1530/ERC-09-0216e
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Discovery of Promising Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), Estrogen Receptor (ER), and Phosphatidylinositol-3-kinase a (PI3Ka) for Personalized Breast Cancer Treatment
    Akinnusi, Precious A.
    Olubode, Samuel O.
    Adebesin, Ayomide O.
    Nana, Toluwani A.
    Shodehinde, Sidiqat A.
    CANCER INFORMATICS, 2022, 21
  • [43] Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HEF12-overexpressing human breast cancer cells
    Zavodovskaya, Marianna
    Campbel, Michael J.
    Maddux, Betty A.
    Shiry, Laura
    Allan, Geoffrey
    Hodges, Leslie
    Kushner, Peter
    Kerner, John A.
    Youngren, Jack F.
    Goldfine, Ira D.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2008, 103 (02) : 624 - 635
  • [44] THE RECEPTOR TYROSINE KINASE P185(HER2) IS EXPRESSED ON A SUBSET OF B-LYMPHOID BLASTS FROM PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA AND CHRONIC MYELOGENOUS LEUKEMIA
    BUHRING, HJ
    SURES, I
    JALLAL, B
    WEISS, FU
    BUSCH, FW
    LUDWIG, WD
    HANDGRETINGER, R
    WALLER, HD
    ULLRICH, A
    BLOOD, 1995, 86 (05) : 1916 - 1923
  • [45] The Novel Role of Cytomorphology from Ultrasound-Guided Fine Needle Aspiration Cytology in Evaluating the Status of Prognostic Factors including Estrogen Receptor, Progesterone Receptor and HER2 in Breast Cancer
    Li, Yunzhu
    Jia, Shijun
    Yao, Yuqi
    Zhou, Yehan
    Li, Shurong
    Li, Jiayu
    Liu, Yang
    ANALYTICAL CELLULAR PATHOLOGY, 2022, 2022
  • [46] Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells (vol 14, pg 648, 2015)
    Canfield, Kaleigh
    Li, Jiaqi
    Wilkins, Owen M.
    Morrison, Meghan M.
    Ung, Matthew
    Wells, Wendy
    Williams, Charlotte R.
    Liby, Karen T.
    Vullhorst, Detlef
    Buonanno, Andres
    Hu, Huizhong
    Schiff, Rachel
    Cook, Rebecca S.
    Kurokawa, Manabu
    CELL CYCLE, 2015, 14 (08) : 1339 - 1341
  • [48] RETRACTION: G Protein-Coupled Receptor Kinase 2 Plays a Relevant Role in Insulin Resistance and Obesity. (Retraction of Vol 59, Pg 2407, 2010)
    Garcia-Guerra, Lucia
    Nieto-Vazquez, Iria
    Vila-Bedmar, Rocio
    Jurado-Pueyo, Maria
    Zalba, Guillermo
    Diez, Javier
    Murga, Cristina
    Fernandez-Veledo, Sonia
    Mayor, Federico
    Lorenzo, Margarita
    DIABETES, 2020, 69 (11) : 2538 - 2538
  • [49] ZD1839, a specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, induces the formation of inactive EGFR/HER2 and EGFR/HER3 heterodimers and prevents heregulin signaling in HER2-overexpressing breast cancer cells
    Anido, J
    Matar, P
    Albanell, J
    Guzmán, M
    Rojo, F
    Arribas, J
    Averbuch, S
    Baselga, J
    CLINICAL CANCER RESEARCH, 2003, 9 (04) : 1274 - 1283